Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.814 USD | -2.98% | -4.55% | +59.61% |
06/05 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
10/04 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.61% | 11.92M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Oppenheimer Downgrades Chemomab Therapeutics to Perform From Outperform, Removes $7 Price Target